Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Somnomed Limited ( (AU:SOM) ) has provided an announcement.
SomnoMed Limited reported a positive cash flow from operating activities amounting to $1.525 million for the quarter ending December 31, 2024. Despite operating gains, the company saw a net cash outflow of $661,000 from investing activities and $26,000 from financing activities, resulting in an overall increase in cash and cash equivalents of $16.404 million, indicating strong cash reserves to support future operations.
More about Somnomed Limited
SomnoMed Limited operates in the healthcare industry, specializing in the development and distribution of oral appliances for the treatment of sleep-related disorders. The company primarily focuses on providing solutions for obstructive sleep apnea, catering to patients and healthcare professionals globally.
YTD Price Performance: 3.12%
Average Trading Volume: 4,787
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $69.01M
See more data about SOM stock on TipRanks’ Stock Analysis page.
